Literature DB >> 9058050

Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat.

M Fendt1, M Koch, H U Schnitzler.   

Abstract

The fear-potentiated startle paradigm is a valuable model for the investigation of the neuronal basis of fear. Previous studies have demonstrated that the neuropeptide corticotropin-releasing factor (CRF) plays an important role in fear-related processes, notably in the potentiation of the acoustic startle response. The present study investigated the role in fear-potentiated startle of CRF in the caudal pontine reticular nucleus, a brain nucleus that mediates the acoustic startle response. First, we showed that the central nucleus of the amygdala gives rise to a CRFergic projection to the caudal pontine reticular nucleus. In the second experiment, we iontophoretically applied CRF to caudal pontine reticular nucleus neurons and extracellularly recorded the activity of these neurons. CRF had a mainly excitatory effect on the tone-evoked activity of the neurons. In our third experiment, we injected the CRF antagonist alpha-helical CRF into the caudal pontine reticular nucleus of awake rats. Here, alpha-helical CRF dose-dependently blocked fear-potentiated startle, but had no effect on the baseline startle amplitude. The present results show that CRF-containing neurons which project from the central nucleus to the caudal pontine reticular nucleus are important for the enhancement of startle by fear, and further characterize the hypothetical neuronal circuitry underlying the expression of fear-potentiated startle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058050     DOI: 10.1111/j.1460-9568.1997.tb01400.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

1.  Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.

Authors:  David L Walker; Gayla Y Paschall; Michael Davis
Journal:  Learn Mem       Date:  2005-03-17       Impact factor: 2.460

2.  Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.

Authors:  Jodi E Gresack; Victoria B Risbrough
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-21       Impact factor: 5.176

3.  5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors.

Authors:  Guangchen Ji; Wei Zhang; Lenin Mahimainathan; Madhusudhanan Narasimhan; Takaki Kiritoshi; Xiuzhen Fan; Jigong Wang; Thomas A Green; Volker Neugebauer
Journal:  J Neurosci       Date:  2016-12-23       Impact factor: 6.167

Review 4.  Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake.

Authors:  Klaus A Miczek; Jasmine J Yap; Herbert E Covington
Journal:  Pharmacol Ther       Date:  2008-08-15       Impact factor: 12.310

5.  Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.

Authors:  C L Pickens; T Adams-Deutsch; S G Nair; B M Navarre; M Heilig; Y Shaham
Journal:  Neuroscience       Date:  2009-10-02       Impact factor: 3.590

6.  Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors.

Authors:  Matthew Hein; Guangchen Ji; Dalton Tidwell; Preston D'Souza; Takaki Kiritoshi; Vadim Yakhnitsa; Edita Navratilova; Frank Porreca; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2021-01-12       Impact factor: 5.250

7.  Regulation of Cued Fear Expression via Corticotropin-Releasing-Factor Neurons in the Ventral Anteromedial Thalamic Nucleus.

Authors:  Yin Lv; Peng Chen; Qing-Hong Shan; Xin-Ya Qin; Xiu-Hong Qi; Jiang-Ning Zhou
Journal:  Neurosci Bull       Date:  2020-10-14       Impact factor: 5.203

8.  Optogenetic Manipulations of Amygdala Neurons Modulate Spinal Nociceptive Processing and Behavior Under Normal Conditions and in an Arthritis Pain Model.

Authors:  Mariacristina Mazzitelli; Kendall Marshall; Andrew Pham; Guangchen Ji; Volker Neugebauer
Journal:  Front Pharmacol       Date:  2021-05-25       Impact factor: 5.988

9.  Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.

Authors:  David Walker; Yong Yang; Emiliangelo Ratti; Mauro Corsi; David Trist; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2008-12-10       Impact factor: 7.853

10.  Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.

Authors:  Edita Navratilova; Guangchen Ji; Caroline Phelps; Chaoling Qu; Matthew Hein; Vadim Yakhnitsa; Volker Neugebauer; Frank Porreca
Journal:  Pain       Date:  2019-04       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.